Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Year of publication: |
2022
|
---|---|
Authors: | Ravi, Srividya |
Publisher: |
Geneva : South Centre |
Subject: | Access to Medicines | Affordable Medicines | Biotherapeutics | Coronavirus | COVID-19 | Favipiravir | Global Health | Health | Intellectual Property | Molnupiravir | Nirmatrelvir | Pandemic | Patent | Patent Offices | Public Health | Remdesivir | Ruxolitinib | Sarilumab | Siltuximab | Tocilizumab |
Series: | Research Paper ; 153 |
---|---|
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Research Report |
Language: | English |
Other identifiers: | 1802132724 [GVK] hdl:10419/262128 [Handle] |
Source: |
-
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya, (2022)
-
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya, (2020)
-
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya, (2020)
- More ...
-
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya, (2020)
-
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya, (2020)
-
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Ravi, Srividya, (2022)
- More ...